2m 2m 2m 2m 2m 2m 2m
Enanta Pharm (ENTA)
NASDAQ
$11.25-$0.78 (-6.48%)
Price as of Jun 03, 2026 4:10 PM EDT- $382.7MMarket Cap
- 67.32%1-Year Change
- BiotechnologyIndustry
Enanta Pharm (ENTA)
$11.25-$0.78 (-6.48%)
ENTA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $12.03 | ||
Change | -$0.64 (-5.05%) | ||
Open | $12.51 | ||
High | $12.60 | ||
Low | $11.91 | ||
Previous Close | $12.67 | ||
Volume | 196,987 | ||
30-Day Average Volume | 226,578 | ||
1-Week Change | -11.09% | ||
1-Month Change | -16.17% | ||
1-Year Change | 67.32% | ||
3-Year Change | -53.61% | ||
5-Year Change | -73.94% | ||
Fundamentals | |||
Shares Outstanding | 29.1M | ||
Total Assets | $314.7M | ||
Market Cap | $382.7M | ||
Enterprise Value | $347.7M | ||
Period: QTR TTM FY | |||
Revenue | $17.2M | ||
Net Income | -$13.1M | ||
Free Cash Flow | -$7.2M | ||
EBIT | -$9.8M | ||
EBITDA | -$8.6M | ||
Net Working Capital | $132.0M | ||
EPS | -$0.45 | ||
Enterprise Value/EBITDA | -41 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 3 | ||
P/E | -29 | ||
PEG | 4 | ||
Price/Free Cash Flow | -53 | ||
Price/Operating Cash Flow | -53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue